Types of Proposals
Proposal Type Instrument Allocation Requests Typical Access Timeframe Proposal Focus Proposal Review Timeframe Page Limit
8-24 hours (must be used during same day) Valid for 3 months Preliminary data or time-sensitive investigations. Scheduled by PNCC staff as time is available. Proposals sent for review monthly. Due 1st of each month. 1 page
Up to 20 days per year allocated in 5-day renewable increments. Valid for up to 2 years Long-term projects of significant impact. Onsite training recommended. Training can be component of proposal or primary focus. PNCC staff or qualified user operation of instrumentation. Proposals sent for review monthly.  Due 1st of each month. 3 pages
Templates for each proposal type are included in the table above. Click on the name of the proposal you are interested to download the template then complete all sections and print a PDF for upload and submission to the EMSL User Portal. The Peer Review page provides a description of the review criterion for reference while the Submit Proposal page includes detailed instructions for how to submit the proposals.

Note: Proposal templates and project types have changed.

  • The original PNCC “Standard” and “Programmatic” Access proposal types have been merged into a single proposal type that is now called “General Access.” All awarded General Access proposals will be given an initial allocation of 120 hours that expires after 6-months. However, upon utilization of the initial allocation, proposal teams can request additional 120 hour allocations for up to 480 hours (20 days) per year, for up to 2 years from the date of the original award. Renewable allocations are not guaranteed. Requests will be evaluated internally based on progress and sample quality/availability, and will be approved by PNCC staff without additional external peer review. All already approved “Programmatic” projects are automatically being converted to General Access projects.

  • The original PNCC “Rapid” Access proposals are now called “Limited Access” proposals. While only minor changes were made to the “Limited Access” template, one key difference is that the 8-24 hour allocation for microscope time is now defined as having to be spent in the same 24 hour period. Thus, “Limited Access” proposals seeking screening of multiple grids can still be granted microscope time, but all grids must be screened at the same time. No multiday screening sessions are allowed on “Limited Access” proposals.

Proposals received by 11:59 PST on the first day of each month will typically be sent for review that month. Proposals submitted after that cutoff will wait until the next month's review cycle. There is no limit to the number of General Access proposals a PI may have as long as the science focus is distinct and non-overlapping. A PI may only have 1 active Limited Access proposal at any time. 

Note on biosafety for all proposed samples: If the sample is, or is derived from, or contains any agent (or its DNA) that can be infectious or toxic in humans, animals or plants (viruses, bacteria, toxins etc.), or is obtained from sources that could potentially harbor (latently) such agents (eg. serum-derived or obtained from human cell lines), then the risk group (RG) must be established, licenses for shipping obtained, and safe operating procedures defined according to biohazard safety level (BSL).  Guidance on risk groups is at https://www.cdc.gov/biosafety/publications/bmbl5/BMBL5_sect_II.pdf and references therein.  The starting point for our review will be the approval from the Institutional Biosafety Committee (IBC) from the applicant's home institution and the protocols on which the approval is based, so please attach both to this proposal after the biosketches. If your final sample might be considered RG1 but preparative work involved steps at BSL2, then a copy of your home-institution IBC approval indicating a down-grading of BSL during the purification will be needed to support that designation. Generally, center staff will oversee approval of RG1 agents, while acceptance of RG2 agents from US institutions will require involvement of OHSU's biosafety officer / IBC which may impact project award timeframes.  Shipping of agents from outside the US often requires additional approval from the CDC and/or USDA, and will be considered on an individual basis. This information must be reported in the proposal using the template provided above. We cannot receive BSL2 samples in liquid form at this time. Only pre-frozen BSL2 samples with IBC documentation can be handled.